Clinical Trials Logo

Clinical Trial Summary

This study will be carried out as a retrospective, non-interventional observational review of medical records for patients in multiple countries with platinum-sensitive recurrent serous ovarian cancer. The objectives are to describe in a real-world population, treatment patterns, BRCA mutation testing and results, overall survival, health care utilization and also to estimate rates of selected treatment- and/or disease-related side effects


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT02262273
Study type Observational
Source AstraZeneca
Contact
Status Completed
Phase N/A
Start date October 2014
Completion date April 2016